尿液代谢物术前预测冠状动脉旁路移植术后急性肾损伤
该研究纳入159例择期行单纯体外循环冠状动脉旁路移植术患者,采用液相色谱-质谱尿液代谢组学分析术前尿液,终点为术后48小时内急性肾损伤。发现5种代谢物组合预测性能良好(AUC 0.89,95%CI 0.82-0.93),优于临床因素模型(AUC 0.63,95%CI 0.53-0.72)。
要点
- 5种尿液代谢物组合可术前预测体外循环冠状动脉旁路移植术后急性肾损伤。
- 代谢物模型AUC 0.89,高于临床因素模型AUC 0.63。
- Bootstrap内部验证调整AUC 0.88,校准曲线一致性良好。
核心结论
- 5种尿液代谢物组合可能作为体外循环冠状动脉旁路移植术后急性肾损伤的术前预警工具。
研究设计与样本
- 前瞻性研究纳入2017年7月7日至2019年5月17日行单纯体外循环冠状动脉旁路移植术的159例患者。
- 术前尿液采用液相色谱-质谱代谢组学分析,终点为术后48小时内急性肾损伤。
主要发现
- 急性肾损伤组(n=55)与非急性肾损伤组(n=104)代谢谱存在显著差异。
- 共28种代谢物在两组间有显著差异。
- 5种代谢物组合(酪氨酰-γ-谷氨酸、脱氧胆酸甘氨酸结合物、5-乙酰氨基-6-氨基-3-甲基尿嘧啶、精氨酰-精氨酸、L-甲硫氨酸)预测AUC为0.89(95%CI 0.82-0.93)。
- 临床因素模型AUC为0.63(95%CI 0.53-0.72)。
- Bootstrap重采样内部验证调整AUC为0.88,校准曲线显示预测与观察一致性良好。
关键数值与推荐
- 代谢物模型预测术后急性肾损伤的AUC为0.89(95%CI 0.82-0.93)。
- 临床因素模型预测术后急性肾损伤的AUC为0.63(95%CI 0.53-0.72)。
- Bootstrap内部验证调整AUC为0.88。
临床怎么用
- 对于拟行体外循环冠状动脉旁路移植术患者,可考虑术前检测尿液代谢物组合以辅助急性肾损伤风险分层。
局限性
- 研究为单中心,样本量159例,需外部验证。
- 仅纳入体外循环冠状动脉旁路移植术患者,结论外推受限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Acute kidney injury is a common complication after on-pump coronary artery bypass grafting. Prediction of acute kidney injury remains a challenge. Our study aims to identify a panel of urine metabolites for preoperative warning of acute kidney injury after on-pump coronary artery bypass grafting. METHODS: A total of 159 patients undergoing isolated on-pump coronary artery bypass grafting were enrolled from July 7, 2017, to May 17, 2019. Preoperative urine samples were analyzed with the approach of liquid chromatography-mass spectrometry-based urine metabolomics. The study end point was the episode of acute kidney injury within 48 hours postoperatively. The predictive performance was determined by the area under the curve and calibration curve. The results were validated using bootstrap resampling. RESULTS: The acute kidney injury (n = 55) and nonacute kidney injury (n = 104) groups showed significant different metabolic profiling. A total of 28 metabolites showed significant differences between the acute kidney injury and nonacute kidney injury groups. A metabolite panel of 5 metabolites (tyrosyl-gamma-glutamate, deoxycholic acid glycine conjugate, 5-acetylamino-6-amino-3-methyluracil, arginyl-arginine, and L-methionine) was discovered to have a good predicting performance (area under the curve, 0.89; 95% confidence interval, 0.82-0.93), which is higher than the clinical factor-based model (area under the curve, 0.63; 95% confidence interval, 0.53-0.72). Internal validation by bootstrap resampling showed an adjusted area under the curve of 0.88, and the calibration curve demonstrated good agreement between prediction and observation in the probability of postoperative acute kidney injury. Decision curve analysis revealed a superior net benefit of the metabolite model over the traditional clinical factor-based model. CONCLUSIONS: We present 5 urine metabolites related to acute kidney injury after coronary artery bypass grafting. This metabolite model may serve as a preoperative warning of acute kidney injury after on-pump coronary artery bypass grafting.
引用
- Tian M, Liu X, Chen L, et al. Urine metabolites for preoperative prediction of acute kidney injury after coronary artery bypass graft surgery. J Thorac Cardiovasc Surg. 2021. PMID: 33994002. doi:10.1016/j.jtcvs.2021.03.118
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。